Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service

VisualDx partners with Emergence Health to support urgent care clinicians with diagnosis and treatment decisions

VisualDx has teamed up with Emergence Health Holdings, an urgent care network across New England, to grant its providers access to AI-fueled assistive technology to support diagnosis and treatment. Amid concurrent crises, staff shortages, and other challenges in medicine, VisualDx is collaborating with an array of organizations to arm clinicians with tech that helps them do their jobs better, faster, and more accurately. In addition to Emergence, the company also recently teamed up with the Vermont Department of Health, HHS’s Biomedical Advanced Research and Development Authority, and the American College of Emergency Physicians to help clinicians diagnose and treat everything from Covid to Monkeypox, polio, the flu, and more.

Biopharma PEG Develops PEG Products For Click Chemistry

Andelyn Biosciences to Manufacture First Gene Therapy for Infantile Neuroaxonal Dystrophy in the US

Huateng Pharma Supplies Semaglutide Intermediates Against Type 2 Diabetes

Genezen appoints Chief Commercial Officer to Executive Leadership Team

Genezen appoints Jeff Whitmore as Chief Commercial Officer

uMotif Announces First New Validated Innovation in eCOA/ePRO Since Paper Instruments Were Deployed on Smartphones

Patent-protected Motif data capture interface from uMotif was proven as an equivalent method to capture Patient Reported Outcome and eDiary data, eliminates reliance on text-based instruments, in a study with 55 participants in 2 randomized groups conducted by SAFIRA Clinical Research at Dublin City University.

Creative Enzymes Expands Its Service Offering with the Launch of Custom Enzyme Blends

Creative Enzymes Provides DNA Molecular Weight Markers and Ladders

CD Genomics Expands Its Sequencing Portfolio with the Launch of Whole Exome Sequencing

MicrobioSeq Boosts Scientific Research with Gene Expression Analysis

Vaxess Adds Fenel Eloi to Board of Directors

Eloi brings more than 30 years of life science leadership experience to Vaxess’ board; will advise company as it moves towards commercialization of MIMIX vaccine patch

Micro-Sphere Launches New Research & Development Services at Swiss Site

Global contract development and manufacturing organisation (CDMO) Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation.

Flywheel Building Federated Data Platform for Development of Unbiased Breast Imaging AI

Flywheel is creating a federated data network aimed at improving AI for breast imaging—on a scale not previously possible.

Zebrafish Disease Model: Developed by Creative Biogene to Support Multiple Therapeutic Areas

IntegrateRNA Develops Premade Circular RNA Products to Satisfy Various Downstream Applications

Microbiosci Develops Data-independent Acquisition Proteomics to Support Molecular Diagnostics

Creative Bioarray Develops More Than 1000 Cell Types Together with Selective Cell Culture Media

Creative Bioarray Releases GMP Grade Cytokines to Support Cell Manufacturing and Cell-based Therapies

Acroscell Develops CiPA in Silico Modeling to Identify and Optimize Drug Candidates